SCHEMBL2175700

SCHEMBL2175700

c1cnc2nnc3nn[nH]c3c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
HCAR2 Q8TDS4 1/20 0.36
PIK3CA P42336 2/20 0.35
MTOR P42345 2/20 0.35
CYP3A4 P08684 1/20 0.33
LMNA P02545 3/20 0.33
PARP1 P09874 3/20 0.33
HSP90AA1 P07900 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
MEN1 O00255 1/20 0.32
HSP90AB1 P08238 1/20 0.32
HTT P42858 1/20 0.32
BLM P54132 1/20 0.32
KMT2A Q03164 1/20 0.32
HIF1A Q16665 1/20 0.32
NPC1 O15118 1/20 0.32
GSK3A P49840 1/20 0.32
GSK3B P49841 1/20 0.32
NUDT1 P36639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3759284 0.81 HCAR2 (0.46) MAPTKDM4EHCAR2PARP1AURKA
SCHEMBL2646080 0.78 GPR3 (0.50) KDM4ELMNAPARP1HTTNPC1
SCHEMBL11195631 0.76 MAPT (0.57) MAPTKDM4EHCAR2MTORCYP3A4
SCHEMBL29376620 0.71
SCHEMBL40861 0.71
SCHEMBL29948103 0.71 NUDT1 (0.40) PARP1NPC1NUDT1AURKA
SCHEMBL21990259 0.69 NUDT1 (0.42) PARP1NUDT1AURKA
SCHEMBL8038689 0.69 NUDT1 (0.42) PARP1NUDT1AURKA
Iodide SCHEMBL16585403 0.69 NUDT1 (0.42) LMNAPARP1NUDT1AURKA
SCHEMBL28611928 0.69 NUDT1 (0.42) PARP1NUDT1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2519526-A1 TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) 2012-11-07 EP disclosed
WO-2011080510-A1 TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2011-07-07 WO disclosed